Roche’s Chief Executive an interview with Swiss media published on Sunday called for Switzerland to pay more for new drugs, to bring prices in line with those paid by Washington.
The Swiss pharmaceutical giant’s US subsidiary Genentech figures among 14 pharmaceutical companies which have so far signed on to US President Donald Trump’s push to cut some US drug prices.
Companies have been making these voluntary deals after Trump sent a letter to 17 major companies over the summer threatening sky-high tariffs if they did not lower drug…
